These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26916311)

  • 1. Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy.
    Abu Saadeh F; Langhe R; Galvin DM; O Toole SA; O'Donnell DM; Gleeson N; Norris LA
    Thromb Res; 2016 Mar; 139():135-41. PubMed ID: 26916311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery.
    Wright JD; Chen L; Jorge S; Burke WM; Tergas AI; Hou JY; Hu JC; Neugut AI; Ananth CV; Hershman DL
    Gynecol Oncol; 2016 Jun; 141(3):531-537. PubMed ID: 27032377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation post elective caesarean section: effect of low molecular weight heparin.
    Ismail SK; Norris L; Muttukrishna S; Higgins JR
    Thromb Res; 2012 Nov; 130(5):799-803. PubMed ID: 22365560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.
    D'Alessio A; Marchetti M; Tartari CJ; Russo L; Cecchini S; Lambregts KWFM; di Mauro D; Falanga A
    Cancer Invest; 2017 Aug; 35(7):490-499. PubMed ID: 28692314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
    Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
    J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation and thrombosis in patients with ovarian malignancy.
    von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
    Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobectomy and postoperative thromboprophylaxis with enoxaparin improve blood hypercoagulability in patients with localized primary lung adenocarcinoma.
    Papageorgiou C; Vandreden P; Marret E; Bonnet F; Robert F; Spyropoulos A; Galea V; Elalamy I; Hatmi M; Gerotziafas GT
    Thromb Res; 2013 Nov; 132(5):584-91. PubMed ID: 24094602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
    Voils SA; Lemon SJ; Jordan J; Riley P; Frye R
    Thromb Res; 2016 Nov; 147():13-15. PubMed ID: 27664391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
    van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
    Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bemiparin in oncology.
    Monreal Bosch M; Vignoli A; Lecumberri Villamediana R; Prandoni P
    Drugs; 2010 Dec; 70 Suppl 2():35-42. PubMed ID: 21162608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Padua prediction score and thrombin generation in hospitalized medical patients.
    Saliba W; Zahalka W; Goldstein L; Ron G; Elias M
    Thromb Res; 2014 Oct; 134(4):803-6. PubMed ID: 25087886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of inferior vena caval filters prior to major surgery in women with gynaecological cancer.
    Adib T; Belli A; McCall J; Ind TE; Bridges JE; Shepherd JH; Barton DP
    BJOG; 2008 Jun; 115(7):902-7. PubMed ID: 18485170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
    Wójcik M; Zaręba L; Undas A
    Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
    Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
    Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in advanced ovarian cancer patients undergoing frontline adjuvant chemotherapy.
    Pant A; Liu D; Schink J; Lurain J
    Int J Gynecol Cancer; 2014 Jul; 24(6):997-1002. PubMed ID: 24905613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism following gynaecological surgery for suspected or confirmed malignancy.
    Hitos K; Wain GV; Fletcher JP
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):23-7. PubMed ID: 21951130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of silent venous thromboembolism before treatment in ovarian cancer.
    Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H
    Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
    Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.
    Claussen C; Rausch AV; Lezius S; Amirkhosravi A; Davila M; Francis JL; Hisada YM; Mackman N; Bokemeyer C; Schmalfeldt B; Mahner S; Langer F
    Thromb Res; 2016 May; 141():39-48. PubMed ID: 26967531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
    Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
    Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.